Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q94472858
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010741.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q94472858
|
024
|
|
|
‡a
0000-0002-3159-5268
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q94472858
|
043
|
|
|
‡c
IT
|
046
|
|
|
‡f
19591204
|
100
|
0 |
|
‡a
Carmine Pinto
‡c
chercheur
‡9
fr
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
Italian oncologist (1959-)
‡9
en
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
oncólogu italianu
‡9
ast
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
Forscher
‡9
de
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
oncologo italiano (1959-)
‡9
it
|
400
|
0 |
|
‡a
Carmine Pinto
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's Cetuximab-Related Radiation Dermatitis in Head-and-Neck Cancer Patients: In Regard to Studer et al. (Int J Radiat Oncol Biol Phys In press)
|
670
|
|
|
‡a
Author's Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology
|
670
|
|
|
‡a
Author's Disparity in the “time to patient access” to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
|
670
|
|
|
‡a
Author's Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy
|
670
|
|
|
‡a
Author's Mesotheliomas due to Asbestos Used in Railroads in Italy
|
670
|
|
|
‡a
Author's Mesotheliomas following exposure to asbestos used in railroads: the Italian cases
|
670
|
|
|
‡a
Author's Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
|
670
|
|
|
‡a
Author's Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|
670
|
|
|
‡a
Author's Results of Long‐term Experimental Carcinogenicity Studies of the Effects of Gasoline, Correlated Fuels, and Major Gasoline Aromatics on Rats
|
670
|
|
|
‡a
Author's Results of Three Life‐Span Experimental Carcinogenicity and Anticarcinogenicity Studies on Tamoxifen in Rats
|
670
|
|
|
‡a
Author's SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/307414577
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|n 2020182273
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ICCU|041
|
909
|
|
|
‡a
(orcid) 0000000231595268
‡9
1
|
919
|
|
|
‡a
cetuximabrelatedradiationdermatitisinheadandneckcancerpatientsinregardtostuderetalintjradiatoncolbiolphysinpress
‡A
Cetuximab-Related Radiation Dermatitis in Head-and-Neck Cancer Patients: In Regard to Studer et al. (Int J Radiat Oncol Biol Phys In press)
‡9
1
|
919
|
|
|
‡a
disparityinthetimetopatientaccesstonewanticancerdrugsinitalianregionsresultsofasurveyconductedbytheitaliansocietyofmedicaloncology
‡A
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology
‡9
1
|
919
|
|
|
‡a
resultsoflongtermexperimentalcarcinogenicitystudiesoftheeffectsofgasolinecorrelatedfuelsandmajorgasolinearomaticsonrats
‡A
Results of Long‐term Experimental Carcinogenicity Studies of the Effects of Gasoline, Correlated Fuels, and Major Gasoline Aromatics on Rats
‡9
1
|
919
|
|
|
‡a
resultsof3lifespanexperimentalcarcinogenicityandanticarcinogenicitystudiesontamoxifeninrats
‡A
Results of Three Life‐Span Experimental Carcinogenicity and Anticarcinogenicity Studies on Tamoxifen in Rats
‡9
1
|
919
|
|
|
‡a
mutationalprofileofmalignantpleuralmesotheliomampminthephase2ramesstudy
‡A
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
‡9
1
|
919
|
|
|
‡a
indicationsregardingthemanagementofinterventionalclinicaltrialswithdrugsduringthecurrentcovid19emergencyinitaly
‡A
Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy
‡9
1
|
919
|
|
|
‡a
primarytumorresponsetopreoperativechemoradiationwithorwithoutoxaliplatininlocallyadvancedrectalcancerpathologicresultsofthestar01randomizedphase3trial
‡A
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
‡9
1
|
919
|
|
|
‡a
mesotheliomasduetoasbestosusedinrailroadsinitaly
‡A
Mesotheliomas due to Asbestos Used in Railroads in Italy
‡9
1
|
919
|
|
|
‡a
sarscov2positivehospitalizedcancerpatientsduringtheitalianoutbreakthecohortstudyinreggioemilia
‡A
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia
‡9
1
|
919
|
|
|
‡a
disparityinthetimetopatientaccesstonewanticancerdrugsinitalianregionsresultsofasurveyconductedbytheitaliansocietyofmedicaloncologyaiom
‡A
Disparity in the “time to patient access” to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
‡9
1
|
919
|
|
|
‡a
mesotheliomasfollowingexposuretoasbestosusedinrailroadstheitaliancases
‡A
Mesotheliomas following exposure to asbestos used in railroads: the Italian cases
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
IT
‡9
1
|
996
|
|
|
‡2
ISNI|0000000508297838
|
996
|
|
|
‡2
DNB|1060699915
|
996
|
|
|
‡2
LC|n 2020182273
|
996
|
|
|
‡2
LC|n 2016023369
|
996
|
|
|
‡2
ISNI|0000000024666326
|
996
|
|
|
‡2
LC|no2019086070
|
996
|
|
|
‡2
BAV|495_248805
|
996
|
|
|
‡2
BLBNB|000507724
|
996
|
|
|
‡2
CAOONL|ncf10073407
|
996
|
|
|
‡2
NII|DA12881797
|
996
|
|
|
‡2
ICCU|LO1V176041
|
996
|
|
|
‡2
LC|no 99088670
|
996
|
|
|
‡2
LC|n 80044159
|
997
|
|
|
‡a
1959 0 lived 1204 0
‡9
1
|
998
|
|
|
‡a
Pinto, Carmine,
‡2
LC|n 2020182273
‡3
suggested
‡3
single date
|
998
|
|
|
‡a
Pinto
‡b
,Carmine
‡2
ICCU|LO1V176041
‡3
single date
|